Latest Tejas Trivedi Shareholdings and Portfolio in 2026

Tejas Trivedi is an experienced investor and a key figure in India’s financial industry. Tejas Trivedi holds a well-diversified portfolio spread across several high-potential sectors. Tejas Trivedi shows strategic insights into both Indian and global markets. His investment choices reflect his strong understanding of business fundamentals, sectoral growth prospects, and risk management. His portfolio includes established companies as well as emerging sectors. This approach mirrors his long-term vision for wealth creation. This blog covers Tejas Trivedi’s stock portfolio in 2026 and analyses the companies he holds and how these investments align with his broader strategic approach.

Tejas Trivedi Portfolio Holdings List 2026

Here’s an overview of Tejas Trivedi’s key investments in 2026, along with their market performance and the current value of his holdings:

Disclaimer: Please note that the above table is for educational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing. The data is derived from Tickertape Stock Screener and is subject to real-time updates.

Who is Tejas Trivedi?

Tejas Trivedi has decades of experience in India’s capital markets. He is one of India’s top investors and began his career in equity research at firms such as Corporate Database and Anvil Group. Today, he stands as a prominent figure in the business and investment sectors. He establishes his investment approach on analysis, sectoral diversification, and long-term growth. He also follows a disciplined approach to risk management and identifies companies with high potential across industries.

Tejas Trivedi’s Key Portfolio Stocks

1. AstraZeneca Pharma India Ltd.: AstraZeneca Pharma India Ltd. develops innovative medicines in oncology, cardiovascular, renal, respiratory, and inflammation segments. The company holds a strong market presence by driving research-based drug development and focusing on patient-centric healthcare solutions.
2. K.C. Denim Ltd.: K.C. Denim Ltd. produces high-quality denim fabric for the textile industry. The company focuses on innovation and sustainability while meeting global demand in the evolving apparel and fashion sectors.
3. D-Link (India) Ltd.: D-Link (India) Ltd. provides networking products and services, including routers, switches, and wireless solutions. It supports both home and business networking, providing reliable, scalable connectivity in the digital space.
4. NOCIL Ltd.: NOCIL Ltd. manufactures rubber chemicals that serve tyre production and other rubber goods. The company contributes to the global supply chain by providing sustainable, high-quality chemical solutions across various industries.
5. Indag Rubber Ltd.: Indag Rubber Ltd. manufactures rubber products for multiple industrial applications. The company serves the automotive, machinery, and other sectors with durable, precise rubber solutions.

Tejas Trivedi Shareholding: Sector-Wise Investments

• Chemicals & Speciality Materials: This is the largest segment in the portfolio. AstraZeneca Pharma India, NOCIL, Thirumalai Chemicals, Ultramarine & Pigments, and Tamilnadu Petroproducts reflect strong exposure to chemicals, intermediates, pigments, and industrial materials. This part of the portfolio is linked to manufacturing demand and speciality product businesses.
• Industrial Products & Components: Companies such as Control Print, High Energy Batteries, Indag Rubber, and Cosmo Ferrites represent industrial and component-focused businesses. These companies operate in areas such as coding solutions, batteries, rubber products, and magnetic materials.
• Technology & Networking: D-Link (India) and ABM Knowledgeware add exposure to technology-led businesses. This segment includes networking products, software, and digital solutions.
• Textiles & Apparel Materials: Sambandam Spinning Mills and K G Denim represent exposure to textile manufacturing. These businesses are linked to the demand for yarn, denim, and fabric.
• Healthcare & Pharma: AstraZeneca Pharma India adds healthcare exposure to the portfolio through the pharmaceutical segment. It reflects a presence in medicine and healthcare-related products.

Tejas Trivedi’s Net Worth

By 2026, his portfolio reached over ₹1,330.9 cr. The steady rise shows his knack for spotting good investments early, especially in sectors poised for long-term growth.

Shares Purchased By Tejas Trivedi in 2026

This addition reflects Tejas Trivedi’s confidence in the company’s long-term growth prospects.

Shares Sold By Tejas Trivedi in 2026

The reductions in the position suggest that Tejas Trivedi is rebalancing his portfolio, potentially to capitalise on better opportunities in other sectors or companies with stronger growth prospects.

Key Highlights of Tejas Trivedi’s Investment Strategy

• Diversified Portfolio: Tejas Trivedi invests across multiple sectors, including pharmaceuticals, technology, and chemicals. Tejas Trivedi manages risk and captures growth from different industries through holdings such as AstraZeneca Pharma and K.C. Denim.
• Long-Term Vision: Trivedi focuses on long-term growth stocks and invests in companies with strong fundamentals. Tejas Trivedi shows patience by holding investments like AstraZeneca Pharma and Atul Ltd. to benefit from steady sectoral growth.
• Selective Risk Management: Trivedi balances high-risk and low-risk assets in his portfolio. He manages volatility by carefully adjusting his holdings, which include companies such as D-Link and Cosmo Ferrites Ltd.
• Focus on Management Quality: Trivedi invests in companies with strong leadership. He considers capable management essential for overcoming challenges and sustaining long-term success, as reflected in his stake in AstraZeneca Pharma India Ltd.
• Research-Driven Approach: Trivedi bases his investments on in-depth research. He analyses financial health and market potential to ensure each stock fits within his long-term strategy.

Tejas Trivedi’s Investment Philosophy

Tejas Trivedi’s philosophy revolves around value investing, fundamentals, and long-term growth:

• Value Investing: Tejas Trivedi follows a value-based approach grounded in fundamentals and long-term growth. He targets companies that remain undervalued and looks for long-term appreciation instead of short-term gains.
• Focus on Fundamentals: He prioritises financial stability, growth potential, and strong management when choosing stocks.
• Patience: He holds his investments for extended periods, allowing his portfolio to grow with market cycles.
• Portfolio Diversification: He spreads his investments across sectors to reduce risk and maintain portfolio stability.
• Adaptability: He stays flexible and adjusts his portfolio to capture emerging opportunities while staying focused on long-term goals.

Conclusion:

Tejas Trivedi’s portfolio highlights his skill in spotting companies with strong growth potential across different sectors. He invests strategically in firms such as AstraZeneca Pharma, K.C. Denim, and Atul Ltd. to create value through research-based, long-term holdings. He follows a strategy based on diversification, fundamental analysis, and risk management, which helps him build a resilient and sizable portfolio.

Frequently Asked Questions About Hemendra Kothari’s Portfolio